Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti… - Pigment Cell & …, 2011 - Wiley Online Library
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

[PDF][PDF] Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti, C Bertolotto - academia.edu
Normal cells possess a limited proliferative life span after which they enter a state of
irreversible growth arrest called replicative senescence that acts as a potent barrier against …

Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti… - Pigment Cell & Melanoma …, 2011 - infona.pl
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

Advances in melanoma senescence and potential clinical application.

S Giuliano, M Ohanna, R Ballotti… - Pigment Cell & …, 2011 - search.ebscohost.com
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti… - Pigment Cell & …, 2011 - inserm.hal.science
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

Advances in melanoma senescence and potential clinical application.

S Giuliano, M Ohanna, R Ballotti… - Pigment Cell & …, 2011 - europepmc.org
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti… - Pigment cell & …, 2011 - pubmed.ncbi.nlm.nih.gov
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti… - Pigment Cell & melanoma …, 2011 - hal.science
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

[PDF][PDF] Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti, C Bertolotto - 2010 - researchgate.net
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …

Advances in melanoma senescence and potential clinical application

S Giuliano, M Ohanna, R Ballotti… - Pigment Cell & Melanoma …, 2011 - infona.pl
Normal cells possess a limited proliferative life span, after which they enter a state of
irreversible growth arrest, called replicative senescence, which acts as a potent barrier …